ArticleGland surgery2026
Radiologically-confirmed dehiscence of the pancreaticojejunal anastomosis following pancreaticoduodenectomy: risk factors and implications for technique.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dehiscence of pancreaticojejunal anastomosis is a direct indicator of severe postoperative pancreatic fistula (POPF). This study aimed to analyze the characteristics of anastomotic dehiscence and identify its associated risk factors, with the goal of informing improved treatment strategies. Methods: We conducted a retrospective analysis of 220 patients who underwent pancreaticoduodenectomy (PD) between 2020 and 2024. The clinical features of patients with dehisced anastomosis were summarized. Risk factors for clinically relevant POPF (CR-POPF) and anastomotic dehiscence were evaluated. A subgroup analysis was performed to assess the impact of continuous versus interrupted suturing on anastomotic dehiscence across different patient populations. Results: The incidences of CR-POPF and anastomotic dehiscence were 31.4% and 10.0%, respectively. Anastomotic dehiscence was typically diagnosed at a median of 7 days after PD. Among these patients, post-pancreatectomy hemorrhage (PPH) occurred in 27.3%, and the 90-day mortality rate was 18.2%. Continuous suturing was identified as an independent risk factor for anastomotic dehiscence in both the entire cohort and the CR-POPF subgroup. Subgroup analysis showed that interrupted suturing was associated with a reduced incidence of anastomotic leakage in male patients, those with body mass index (BMI) ≥23 kg/m Conclusions: Continuous suturing may be associated with dehiscence of pancreaticojejunal anastomosis in high-risk patients, suggesting that the choice of technique should be individualized. For cases involving high risks, meticulously interrupted suturing may be more effective in preventing anastomotic dehiscence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.